Principles of Physiological Closed-Loop Controllers in Neuromodulation
Fuente:
arXiv
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2025
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866915652573331456 |
|---|---|
| author | Marks, Victoria S. vanRheede, Joram Karantonis, Dean Esteller, Rosana Dinsmoor, David Fleming, John Larson, Barrett Desborough, Lane Single, Peter Raike, Robert DHaese, Pierre-Francois Englot, Dario J. Lempka, Scott North, Richard Poree, Lawrence Bikson, Marom Denison, Tim J. |
| author_facet | Marks, Victoria S. vanRheede, Joram Karantonis, Dean Esteller, Rosana Dinsmoor, David Fleming, John Larson, Barrett Desborough, Lane Single, Peter Raike, Robert DHaese, Pierre-Francois Englot, Dario J. Lempka, Scott North, Richard Poree, Lawrence Bikson, Marom Denison, Tim J. |
| contents | As neurostimulation devices increasingly incorporate closed-loop functionality, the greater design complexity brings additional requirements for risk management and special considerations to optimise benefit. This manuscript creates a common framework upon which all current and planned neuromodulation-based physiological closed-loop controllers (PCLCs) can be mapped including integration of the Technical Considerations of Medical Devices with Physiologic Closed-Loop Control Technology guidance published in 2023 by the United States Food and Drug Administration (FDA), a classification of feedback (reactive) and feedforward (predictive) biomarkers, and control systems theory. We explain risk management in the context of this framework and illustrate its applications for three exemplary technologies. This manuscript serves as guidance to the emerging field of PCLCs in neuromodulation, mitigating risk through standardized nomenclature and a systematic outline for rigorous device development, testing, and implementation. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2508_11422 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Principles of Physiological Closed-Loop Controllers in Neuromodulation Marks, Victoria S. vanRheede, Joram Karantonis, Dean Esteller, Rosana Dinsmoor, David Fleming, John Larson, Barrett Desborough, Lane Single, Peter Raike, Robert DHaese, Pierre-Francois Englot, Dario J. Lempka, Scott North, Richard Poree, Lawrence Bikson, Marom Denison, Tim J. Systems and Control Neurons and Cognition As neurostimulation devices increasingly incorporate closed-loop functionality, the greater design complexity brings additional requirements for risk management and special considerations to optimise benefit. This manuscript creates a common framework upon which all current and planned neuromodulation-based physiological closed-loop controllers (PCLCs) can be mapped including integration of the Technical Considerations of Medical Devices with Physiologic Closed-Loop Control Technology guidance published in 2023 by the United States Food and Drug Administration (FDA), a classification of feedback (reactive) and feedforward (predictive) biomarkers, and control systems theory. We explain risk management in the context of this framework and illustrate its applications for three exemplary technologies. This manuscript serves as guidance to the emerging field of PCLCs in neuromodulation, mitigating risk through standardized nomenclature and a systematic outline for rigorous device development, testing, and implementation. |
| title | Principles of Physiological Closed-Loop Controllers in Neuromodulation |
| topic | Systems and Control Neurons and Cognition |
| url | https://arxiv.org/abs/2508.11422 |